MUMBAI, Mar 20: Pharma major, Aurobindo Pharma said that an US Food & Drug Administration (USFDA) has granted the tentativehas
granted the tentative approval for Lacosamide Tablets 50mg, 100mg,
150mg and 200mg.
Lacosamide tablets are the generic equivalent of USB Inc’s Vimpat Tablets and used in the treatment of partial-onset seizures in patients with epilepsy aged 17 years. This ANDA contains a Paragraph IV certification and is currently
under litigation in the United States District Court for the District of Delaware, the company said in a statement.
(UNI)
Trending Now
E-Paper
Follow our WhatsApp channel